Related Experiment Video
Updated: Jun 20, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Adeno-Associated Virus 5 Protein Particles Produced by E. coli Cell-Free Protein Synthesis
Danielle Deuker1, Ernest Asilonu2, Daniel G Bracewell1
1Department of Biochemical Engineering, University College London, Bernard Katz Building, Gower Street, London, WC1E 6BT, United Kingdom.
This study demonstrates E. coli cell-free protein synthesis for producing AAV5 virus-like particles. This method offers a rapid and cost-effective alternative for generating biologically active viral vectors for gene therapy and vaccines.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- Recombinant adeno-associated viruses (rAAVs) are crucial for gene therapy and vaccine development.
- Current rAAV manufacturing is expensive and slow, necessitating alternative production methods.
Purpose of the Study:
- To explore the potential of Escherichia coli-based cell-free protein synthesis (CFPS) for producing recombinant adeno-associated virus serotype 5 (AAV5) virus-like particles (VLPs).
Main Methods:
- Expressed AAV5 virus protein 3 (VP3) constructs using E. coli-based CFPS at different temperatures (18°C and 37°C).
- Utilized N-terminally Strep-tag II for affinity purification of VP3.
- Characterized particles using Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM).
- Assessed VLP biological activity through cellular internalization assays in HeLa cells.
Main Results:
- Lower temperatures (18°C) significantly increased the solubility of AAV5 VP3, yielding ~90% more soluble protein compared to 37°C.
- N-terminal Strep-tag II facilitated efficient isolation of VP3 via affinity chromatography.
- DLS and TEM confirmed the formation of approximately 20 nm particles.
- The produced AAV5 VLPs demonstrated biological activity, successfully internalizing into HeLa cells.
Conclusions:
- E. coli-based CFPS is a viable and innovative platform for rapid synthesis of AAV5 VLPs.
- This method yields biologically active AAV VLPs, showing promise for gene therapy and vaccine applications.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Bacterial Gastroenteritis
Hepatitis
Amebiasis
Appendicitis

